Clinical trials in amyotrophic lateral sclerosis: The tenuous past and the promising future

被引：9

作者：

Choudry, RB ^{[1
]}

Cudkowicz, ME ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Neurol Clin Trials Unit, Dept Neurol, Boston, MA 02114 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 45卷 / 12期

关键词：

amyotrophic lateral sclerosis; clinical trials; drug trials;

D O I：

10.1177/0091270005282631

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The post decade of research in amyotrophic lateral sclerosis has contributed to a greater understanding of the disease-process, the development of relevant animal models, and the identification of several therapeutic approaches that may delay disease progression. Completed and ongoing clinical trials and the process of selecting drugs for clinical trials are presented.

引用

页码：1334 / 1344

页数：11

共 50 条

[31] The promise of stem cells in amyotrophic lateral sclerosis: a review of clinical trials
Khalid, Muhammad Usman
Masroor, Taleaa
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (02) : S138 - S142
[32] A PLACEBO ARM IS NOT ALWAYS NECESSARY IN CLINICAL TRIALS OF AMYOTROPHIC LATERAL SCLEROSIS
Gordon, Paul H.
MUSCLE & NERVE, 2009, 39 (06) : 858 - 860
[33] Methodological Quality of Clinical Trials in Amyotrophic Lateral Sclerosis: A Systematic Review
Pupillo, Elisabetta
Al-Chalabi, Ammar
Sassi, Serena
Arippol, Emilio
Tinti, Lorenzo
Vitelli, Eugenio
Copetti, Massimiliano
Leone, Maurizio A.
Bianchi, Elisa
JOURNAL OF NEUROMUSCULAR DISEASES, 2024, 11 (04) : 749 - 765
[34] Geographical distribution of clinical trials in amyotrophic lateral sclerosis: a scoping review
Garcia-Parra, Beliu
Guiu, Josep M.
Povedano, Monica
Marino, Eduardo L.
Modamio, Pilar
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2024, 25 (3-4) : 376 - 381
[35] Phrenic nerve study as outcome in clinical trials for amyotrophic lateral sclerosis
Pinto, Susana
De Carvalho, Mamede
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2021, 22 : 9 - 13
[36] How can we improve clinical trials in amyotrophic lateral sclerosis?
Paul H. Gordon
Vincent Meininger
Nature Reviews Neurology, 2011, 7 : 650 - 654
[37] Systematic review of the methodological quality of clinical trials in Amyotrophic Lateral Sclerosis
Pupillo, Elisabetta
Sassi, Serena
Arippol, Emilio
Tinti, Lorenzo
Vitelli, Eugenio
Bianchi, Elisa
Al-Chalabi, Ammar
Leone, Maurizio
MUSCLE & NERVE, 2023, 68 : S47 - S47
[38] Innovating Clinical Trials for Amyotrophic Lateral Sclerosis Challenging the Established Order
van Eijk, Ruben P. A.
Nikolakopoulos, Stavros
Roes, Kit C. B.
Kendall, Lindsay
Han, Steve S.
Lavrov, Arseniy
Epstein, Noam
Kliest, Tessa
de Jongh, Adriaan D.
Westeneng, Henk-Jan
Al-Chalabi, Ammar
Van Damme, Philip
Hardiman, Orla
Shaw, Pamela J.
McDermott, Christopher J.
Eijkemans, Marinus J. C.
van den Berg, Leonard H.
NEUROLOGY, 2021, 97 (11) : 528 - 536
[39] Retention and Protocol Adherence in Amyotrophic Lateral Sclerosis (ALS) Clinical Trials
Atassi, Nazem
Titus, Sarah
Shapiro, Jordan
Levine-Weinberg, Mark
Deng, Jing
Yu, Hong
Yerramilli-Rao, Padmaja
Cudkowicz, Merit
NEUROLOGY, 2011, 76 (09) : A584 - A584
[40] Clinical and Genetic Aspects of Juvenile Amyotrophic Lateral Sclerosis: A Promising Era Emerges
de Souza, Paulo Victor Sgobbi
Serrano, Paulo de Lima
Farias, Igor Braga
Machado, Roberta Ismael Lacerda
Badia, Bruno de Mattos Lombardi
de Oliveira, Helvia Bertoldo
Barbosa, Alana Strucker
Pereira, Camila Alves
Moreira, Vanessa de Freitas
Chieia, Marco Antonio Troccoli
Barbosa, Adriel Rego
Braga, Vinicius Lopes
Pinto, Wladimir Bocca Vieira de Rezende
Oliveira, Acary Souza Bulle
GENES, 2024, 15 (03)

← 1 2 3 4 5 →